Group B streptococcus

[1]  A. Schuchat,et al.  Impact of a risk-based prevention policy on neonatal group B streptococcal disease. , 1998, American journal of obstetrics and gynecology.

[2]  T. Asrat,et al.  Potential consequences of widespread antepartal use of ampicillin. , 1998, American journal of obstetrics and gynecology.

[3]  D. Kasper,et al.  Antibody responses in invasive group B streptococcal infection in adults. , 1998, The Journal of infectious diseases.

[4]  R. Faix,et al.  Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin , 1998, Obstetrics and gynecology.

[5]  T. Lieu,et al.  Neonatal Group B Streptococcal Infection in a Managed Care Population , 1998, Obstetrics and gynecology.

[6]  A. Schuchat.  Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms , 1998, Clinical Microbiology Reviews.

[7]  B. Stoll,et al.  Maternal carriage of group B streptococci in developing countries. , 1998, The Pediatric infectious disease journal.

[8]  C. Baker,et al.  Antimicrobial Susceptibilities of Group B Streptococci Isolated between 1992 and 1996 from Patients with Bacteremia or Meningitis , 1998, Antimicrobial Agents and Chemotherapy.

[9]  A. Schuchat,et al.  Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. , 1998, The Journal of infectious diseases.

[10]  J. Strauss,et al.  Premature rupture of the fetal membranes. , 1998, The New England journal of medicine.

[11]  S F Bottoms,et al.  The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network. , 1998, American journal of public health.

[12]  J. Miranda,et al.  Timing of Intrapartum Ampicillin and Prevention of Vertical Transmission of Group B Streptococcus , 1998, Obstetrics and gynecology.

[13]  H. Jeffery,et al.  Eight-Year Outcome of Universal Screening and Intrapartum Antibiotics for Maternal Group B Streptococcal Carriers , 1998, Pediatrics.

[14]  L. Cashin-Hemphill,et al.  Hormone-replacement therapy compared with simvastatin for postmenopausal women with hypercholesterolemia. , 1998, The New England journal of medicine.

[15]  N. F. Jacobs,et al.  Neonatal early-onset Escherichia coli disease. The effect of intrapartum ampicillin. , 1998, Archives of pediatrics & adolescent medicine.

[16]  A. Schuchat,et al.  Opportunities for Prevention of Perinatal Group B Streptococcal Disease: A Multistate Surveillance Analysis , 1997, Obstetrics and gynecology.

[17]  G. Cutter,et al.  The Pediatric Costs of Strategies for Minimizing the Risk of Early‐Onset Group B Streptococcal Disease , 1997, Obstetrics and gynecology.

[18]  A. Schuchat,et al.  Preventing neonatal Group B streptococcal disease: The role of the clinical microbiology laboratory , 1997 .

[19]  R. Biggar,et al.  Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in malawi: clinical trial , 1997, BMJ.

[20]  K. Boyer,et al.  Prevention of early-onset neonatal group B streptococcal disease. , 1997, Pediatrics.

[21]  P. Bétrémieux,et al.  Selective intrapartum anti-bioprophylaxy of group B streptococci infection of neonates: a prospective study in 2454 subsequent deliveries. , 1997, European journal of obstetrics, gynecology, and reproductive biology.

[22]  L. Wright,et al.  Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. , 1997, Pediatrics.

[23]  R. Goldenberg,et al.  Sexually transmitted diseases and adverse outcomes of pregnancy. , 1997, Clinics in perinatology.

[24]  C. Baker,et al.  Group B streptococcal infections. , 1997, Clinics in perinatology.

[25]  W. Gozansky,et al.  Prevention practices for perinatal group B streptococcal disease: A multi‐state surveillance analysis , 1997, Obstetrics and gynecology.

[26]  D. Kasper,et al.  Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. , 1996, The Journal of clinical investigation.

[27]  A. Schuchat,et al.  The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. , 1996 .

[28]  R. Shain,et al.  Sexual Behavior and Vaginal Colonization by Group B Streptococcus Among Minority Women , 1996, Obstetrics and gynecology.

[29]  C. Baker.  Inadequacy of rapid immunoassays for intrapartum detection of group B streptococcal carriers , 1996, Obstetrics and gynecology.

[30]  A. Schuchat,et al.  Prevention of perinatal group B streptococcal disease : a public health perspective , 1996 .

[31]  J. Siegel,et al.  Prevention of early‐onset group B streptococcal disease: another look at single‐dose penicillin at birth , 1996, Obstetrics and gynecology.

[32]  R. Edelman,et al.  Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. , 1996, American journal of obstetrics and gynecology.

[33]  A. Schuchat,et al.  Invasive group B streptococcal disease: the emergence of serotype V. , 1996, The Journal of infectious diseases.

[34]  Mary Frances Cotch,et al.  Association between Bacterial Vaginosis and Preterm Delivery of a Low-Birth-Weight Infant , 1995 .

[35]  B. Sibai,et al.  The accuracy and patient preference for self-collected group B Streptococcus cultures. , 1995, American journal of obstetrics and gynecology.

[36]  A. Schuchat,et al.  Risk Factors for Group B Streptococcal Disease in Adults , 1995, Annals of Internal Medicine.

[37]  B. Sibai,et al.  Prenatal screening for group B Streptococcus. II. Impact of antepartum screening and prophylaxis on neonatal care. , 1995, American journal of obstetrics and gynecology.

[38]  A. Adriaanse,et al.  Randomized study of vaginal chlorhexidine disinfection during labor to prevent vertical transmission of group B streptococci. , 1995, European journal of obstetrics, gynecology, and reproductive biology.

[39]  M. Krohn,et al.  The Genital Flora of Women with Intraamniotic Infection , 1995 .

[40]  D. Isaacs,et al.  Prevention of Neonatal Group B Streptococcal Sepsis: Is Routine Antenatal Screening Appropriate , 1995, The Australian & New Zealand journal of obstetrics & gynaecology.

[41]  J. Carey,et al.  Outcome of the Vaginal Infections and Prematurity Study: results of a clinical trial of erythromycin among pregnant women colonized with group B streptococci. , 1995, American Journal of Obstetrics and Gynecology.

[42]  D. Kasper,et al.  Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. , 1995, The Journal of infectious diseases.

[43]  B. Frentzen,et al.  Peripartum infection associated with vaginal group B streptococcal colonization , 1994, Obstetrics and Gynecology.

[44]  T. Miyoshi,et al.  Neonatal Group B Streptococcal Sepsis During 2 Years of a Universal Screening Program , 1994, Obstetrics and gynecology.

[45]  G. Cutter,et al.  Strategies for the Prevention of Early‐Onset Neonatal Group B Streptococcal Sepsis: A Decision Analysis , 1994, Obstetrics and gynecology.

[46]  N. Patel,et al.  Risk of preterm delivery in pregnant women with group B streptococcal urinary infections or urinary antibodies to group B streptococcal and E. coli antigens , 1994, British journal of obstetrics and gynaecology.

[47]  A. Schuchat,et al.  Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development. , 1994, Epidemiologic reviews.

[48]  A. Schuchat,et al.  A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. , 1993, The New England journal of medicine.

[49]  A. Schuchat,et al.  Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. , 1992, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[50]  F. Plummer,et al.  The Role of Maternal Syphilis, Gonorrhoea and HIV-1 Infections in Spontaneous Abortion , 1992, International journal of STD & AIDS.

[51]  K. Tullus,et al.  Prevention of excess neonatal morbidity associated with group B streptococci by vaginal chlorhexidine disinfection during labour , 1992, The Lancet.

[52]  R. Matorras,et al.  Intrapartum chemoprophylaxis of early-onset group B streptococcal disease , 1991 .

[53]  S. Garland,et al.  Group B Streptococcus (GBS) and Neonatal Infections: The Case for Intrapartum Chemoprophylaxis , 1991, The Australian & New Zealand journal of obstetrics & gynaecology.

[54]  A. Schuchat,et al.  Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. , 1990, The Journal of infectious diseases.

[55]  J. Shiloach,et al.  Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid , 1990, Infection and immunity.

[56]  B. Gray,et al.  Seroepidemiology of group B streptococcus type III colonization at delivery. , 1989, The Journal of infectious diseases.

[57]  J. Walsh,et al.  Group B streptococcal disease: its importance in the developing world and prospect for prevention with vaccines. , 1989, The Pediatric infectious disease journal.

[58]  R. Matorras,et al.  Group B streptococcus and premature rupture of membranes and preterm delivery. , 1989, Gynecologic and obstetric investigation.

[59]  D. Kasper,et al.  Immunization of Pregnant Women with a Polysaccharide Vaccine of Group B Streptococcus , 1988 .

[60]  E. Newton,et al.  Group B Streptococcus and Preterm Rupture Membranes , 1988, Obstetrics and gynecology.

[61]  A. Thomsen,et al.  Group B streptococci in the lower urogenital tract and late abortions. , 1988, American journal of obstetrics and gynecology.

[62]  K. Bremme,et al.  Neonatal septicemia due to group B streptococci — Perinatal risk factors and outcome of subsequent pregnancies , 1988, Journal of perinatal medicine.

[63]  R. Sweet,et al.  Chlamydia trachomatis infection and pregnancy outcome. , 1987, American journal of obstetrics and gynecology.

[64]  A. Thomsen,et al.  ANTIBIOTIC ELIMINATION OF GROUP-B STREPTOCOCCI IN URINE IN PREVENTION OF PRETERM LABOUR , 1987, The Lancet.

[65]  B. Gray,et al.  Group B streptococcal carriage and disease: a 6-year prospective study. , 1987, The Journal of pediatrics.

[66]  K. Boyer,et al.  Prevention of early‐onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis , 1986, The New England journal of medicine.

[67]  Lim,et al.  Reduction of morbidity and mortality rates for neonatal group B streptococcal disease through early diagnosis and chemoprophylaxis , 1986, Journal of clinical microbiology.

[68]  R. Rivers,et al.  Group B streptococcal colonisation and the outcome of pregnancy. , 1986, The Journal of infection.

[69]  D. Kasper,et al.  Group B streptococcal vaccines. , 1985, Reviews of infectious diseases.

[70]  R. Mayon-White.  The incidence of GBS disease in neonates in different countries. , 1985, Antibiotics and chemotherapy.

[71]  K. Dinesen,et al.  RUPTURE OF FETAL MEMBRANES AND PREMATURE DELIVERY ASSOCIATED WITH GROUP B STREPTOCOCCI IN URINE OF PREGNANT WOMEN , 1984, The Lancet.

[72]  K. Boyer,et al.  Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale. , 1983, The Journal of infectious diseases.

[73]  K. Boyer,et al.  Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. , 1983, The Journal of infectious diseases.

[74]  Jane M. Deeley,et al.  The effect of intrapartum chemoprophylaxis on the vertical transmission of group B streptococci , 1983, British journal of obstetrics and gynaecology.

[75]  J. Klein,et al.  Infectious Diseases of the Fetus and Newborn Infant , 1983 .

[76]  C. Rosenfeld,et al.  SINGLE-DOSE PENICILLIN PROPHYLAXIS OF NEONATAL GROUP-B STREPTOCOCCAL DISEASE Conclusion of a 41 Month Controlled Trial , 1982, The Lancet.

[77]  M. Pass,et al.  Puerperal and perinatal infections with group B streptococci. , 1982, American journal of obstetrics and gynecology.

[78]  L. S. James,et al.  Premature rupture of membranes, preterm delivery, and group B streptococcal colonization of mothers. , 1981, American journal of obstetrics and gynecology.

[79]  N. Svenningsen,et al.  Obstetrical care in future pregnancies after fetal loss in group B streptococcal septicemia. A prevention program based on bacteriological and immunological follow-up. , 1981, European journal of obstetrics, gynecology, and reproductive biology.

[80]  H. Dillon,et al.  A prospective study of group B streptococcal bacteriuria in pregnancy. , 1981, American journal of obstetrics and gynecology.

[81]  E. Mason,et al.  Ampicillin prevents intrapartum transmission of group B streptococcus. , 1979, JAMA.

[82]  D. Kasper,et al.  Electron microscopic definition of surface antigens of group B Streptococcus. , 1979, Journal of Infectious Diseases.

[83]  C. Hobel,et al.  Epidemiology of group B Streptococcus: longitudinal observations during pregnancy. , 1978, The Journal of infectious diseases.

[84]  D. Kasper,et al.  Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. , 1976, The New England journal of medicine.

[85]  M. Mccarty,et al.  Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens , 1975, The Journal of experimental medicine.